Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech Short Candidates -- Ignore unavailable to you. Want to Upgrade?

To: scaram(o)uche who wrote (149)	12/25/2001 10:42:34 PM
From: tuck	Read Replies (1) \| Respond to of 897

Rick, Over on the Valuation thread you floated the concept of shorting TXBI. I was wondering if you were serious. Their focus is cardiovascular. Do you consider them also-rans compared to other biotechs in the field? They don't seem to have much to do with wine (aside: the University of Texas actually considered doing some wine making, but I never heard what came of it; I thought for a moment there might be a connection, but no). You consider Chalone's offerings more efficacious, I gather. Cheers, Tuck